跳至主要内容
临床试验/NCT02227420
NCT02227420已完成3 期

Effects of IL-1 Beta on the Hypothalamic-pituitary-adrenal (HPA) Axis in Obese Persons - the CortIL-Study

University Hospital, Basel, Switzerland1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2014年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
76
试验地点
1
主要终点
Morning cortisol levels

研究概览

简要总结

In obese individuals cortisol production and secretion is increased but the underlying mechanism is not known. Obesity leads to a pathological activation of the innate immune system partly driven by tissue production of IL-1β. Furthermore, IL-1β is also known to stimulate the release of adrenocorticotropin hormone (ACTH). Therefore, the investigators hypothesise that in obese individuals tissue inflammation stimulates ACTH via IL-1β, thereby explaining the observed hypercortisolism.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80 years
  • BMI >30kg/m2 and at least 1 manifestations of the metabolic syndrome (i.e. diabetes/ prediabetes, hypertension, dyslipidemia)
  • Willingness to use contraceptive measures adequate to prevent becoming pregnant

排除标准

  • Medication with glucocorticosteroids
  • Known Cushing Syndrome
  • Pregnancy or breast feeding
  • Clinical signs of infection in the week before inclusion or history of a severe infection during the last 2 months
  • Hematologic disease (leukocyte count < 1.5x109/l, hemoglobin <11 g/dl, platelets <100 x 103/ul)
  • Kidney disease (creatinine-clearance < 30ml/min))
  • Liver disease (transaminases >4x upper normal range)
  • Active carcinoma
  • History of tuberculosis
  • Alcohol consumption >40g/d for men, >30g/d for women
  • Known allergy towards anakinra
  • Subject refusing or unable to give written informed consent

研究组 & 干预措施

Anakinra

Experimental

Anakinra 100mg s.c. x 5

干预措施: Anakinra (Drug)

结局指标

主要结局

Morning cortisol levels

时间窗: 14 days

次要结局

  • impact of anakinra/Kineret® on other pituitary and peripheral hormones, such as: ACTH, TSH, fT4, GH, IGF-1, LH, FSH, testosterone copeptin, IL-6, CRP, leukocyte count and body temperature.(14 days)
  • effect of anakinra/Kineret® on salivary cortisol, free urinary cortisol, and serum cortisol levels after an overnight dexamethasone suppression test(14 days)
  • correlation between the percentage of body fat or body mass index, and suppression of cortisol levels after injection of anakinra/Kineret®(14 days)
  • comparison of 1mg and 2mg dexamethasone suppression test(4 weeks)
  • correlation between inflammatory parameters with cortisol levels(14 days)

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验